Loading
PhAST
PhAST Diagnostics develops an AI imaging technology for combating antibiotic resistance. Its cloud-based platform provides clinical decision support for doctors, workflow improvement for hospitals, and helps accelerate the drug development process for pharmaceutical companies.
Funding
Every round, secondary, debt facility or acquisition involving PhAST that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—